BRIEF published on 04/30/2024 at 18:05, 1 year 10 months ago Breakthrough in Treatment for Macular Degeneration Blindness by Mesogen Inc. Biotechnology Healthcare Innovation Mesogen Inc Macular Degeneration Stem Cell Treatment
PRESS RELEASE published on 04/30/2024 at 18:00, 1 year 10 months ago Texas Company's Mission to Cure Macular Degeneration Blindness Mesogen Inc. from The Woodlands, Texas, developed a transplantable RPE patch for Macular Degeneration Blindness using autologous stem cells with no teratoma tumor risk Stem Cells Treatment Mesogen Inc. Macular Degeneration Blindness RPE Patch
Published on 03/26/2026 at 12:59, 2 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 12:45, 16 minutes ago Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia
Published on 03/26/2026 at 12:45, 16 minutes ago Electric Royalties Provides Update on Critical Metals Royalty Portfolio
Published on 03/26/2026 at 12:30, 31 minutes ago Nextech3D.ai Expands Blockchain Ticketing Payments to Apple Pay and Google Pay, Advancing Platform Readiness for Adoption
Published on 03/26/2026 at 12:45, 16 minutes ago Original-Research: CLINUVEL Pharmaceuticals Limited (von Parmantier & Cie. GmbH): Buy
Published on 03/26/2026 at 12:20, 40 minutes ago North Peak Closes Second and Final Tranche of Previously Announced Non-Brokered Private Placement, Raising Total Funds of $5.675 Million
Published on 03/26/2026 at 12:17, 44 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 03/26/2026 at 12:05, 56 minutes ago Artlist Expands Its AI Platform with Professional-Grade AI Music for Video Production
Published on 03/26/2026 at 11:56, 1 hour 5 minutes ago IVU continues its growth trajectory in the 2025 financial year
Published on 03/26/2026 at 07:30, 5 hours 31 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 18 hours 30 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 19 hours 16 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
